Peter Schenk
Intensive Care Unit
Department of Internal Medicine 4
Department of Internal Medicine
University of Vienna
Austria
Name/email consistency: high
- Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Schenk, P., Schöniger-Hekele, M., Fuhrmann, V., Madl, C., Silberhumer, G., Müller, C. Gastroenterology (2003)
- Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Schenk, P., Fuhrmann, V., Madl, C., Funk, G., Lehr, S., Kandel, O., Müller, C. Gut (2002)
- Intravenous magnesium sulfate for bronchial hyperreactivity: a randomized, controlled, double-blind study. Schenk, P., Vonbank, K., Schnack, B., Haber, P., Lehr, S., Smetana, R. Clin. Pharmacol. Ther. (2001)
- Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Schenk, P., Rosenkranz, A.R., Wölfl, G., Hörl, W.H., Traindl, O. Am. J. Kidney Dis. (2000)
- Accuracy of echocardiographic right ventricular parameters in patients with different end-stage lung diseases prior to lung transplantation. Schenk, P., Globits, S., Koller, J., Brunner, C., Artemiou, O., Klepetko, W., Burghuber, O.C. J. Heart Lung Transplant. (2000)
- Methylene blue improves the hepatopulmonary syndrome. Schenk, P., Madl, C., Rezaie-Majd, S., Lehr, S., Müller, C. Ann. Intern. Med. (2000)
- Inhaled nitric oxide in a patient with severe pulmonary embolism. Schenk, P., Mittermayer, C., Ratheiser, K. Ann. Emerg. Med (1999)
